These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 18694442

  • 1. Oral administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation.
    Shafton AD, Sanger GJ, Witherington J, Brown JD, Muir A, Butler S, Abberley L, Shimizu Y, Furness JB.
    Neurogastroenterol Motil; 2009 Jan; 21(1):71-7. PubMed ID: 18694442
    [Abstract] [Full Text] [Related]

  • 2. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists.
    Charoenthongtrakul S, Giuliana D, Longo KA, Govek EK, Nolan A, Gagne S, Morgan K, Hixon J, Flynn N, Murphy BJ, Hernández AS, Li J, Tino JA, Gordon DA, DiStefano PS, Geddes BJ.
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1178-86. PubMed ID: 19252061
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of the ghrelin receptor agonist TZP-101 on colonic transit in a rat model of postoperative ileus.
    Fraser GL, Venkova K, Hoveyda HR, Thomas H, Greenwood-Van Meerveld B.
    Eur J Pharmacol; 2009 Feb 14; 604(1-3):132-7. PubMed ID: 19121631
    [Abstract] [Full Text] [Related]

  • 6. GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility.
    Sanger GJ, Westaway SM, Barnes AA, Macpherson DT, Muir AI, Jarvie EM, Bolton VN, Cellek S, Näslund E, Hellström PM, Borman RA, Unsworth WP, Matthews KL, Lee K.
    Neurogastroenterol Motil; 2009 Jun 14; 21(6):657-64, e30-1. PubMed ID: 19374732
    [Abstract] [Full Text] [Related]

  • 7. Contrasting effects of ghrelin and des-acyl ghrelin on the lumbo-sacral defecation center and regulation of colorectal motility in rats.
    Hirayama H, Shiina T, Shima T, Kuramoto H, Takewaki T, B Furness J, Shimizu Y.
    Neurogastroenterol Motil; 2010 Oct 14; 22(10):1124-31. PubMed ID: 20584261
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The mechanism of enhanced defecation caused by the ghrelin receptor agonist, ulimorelin.
    Pustovit RV, Callaghan B, Kosari S, Rivera LR, Thomas H, Brock JA, Furness JB.
    Neurogastroenterol Motil; 2014 Feb 14; 26(2):264-71. PubMed ID: 24304447
    [Abstract] [Full Text] [Related]

  • 10. Evidence that stimulation of ghrelin receptors in the spinal cord initiates propulsive activity in the colon of the rat.
    Shimizu Y, Chang EC, Shafton AD, Ferens DM, Sanger GJ, Witherington J, Furness JB.
    J Physiol; 2006 Oct 01; 576(Pt 1):329-38. PubMed ID: 16873401
    [Abstract] [Full Text] [Related]

  • 11. Site and mechanism of the colokinetic action of the ghrelin receptor agonist, HM01.
    Naitou K, Mamerto TP, Pustovit RV, Callaghan B, Rivera LR, Chan AJ, Ringuet MT, Pietra C, Furness JB.
    Neurogastroenterol Motil; 2015 Dec 01; 27(12):1764-71. PubMed ID: 26416336
    [Abstract] [Full Text] [Related]

  • 12. A ghrelin receptor agonist is an effective colokinetic in rats with diet-induced constipation.
    Pustovit RV, Furness JB, Rivera LR.
    Neurogastroenterol Motil; 2015 May 01; 27(5):610-7. PubMed ID: 25616061
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats.
    Salomé N, Haage D, Perrissoud D, Moulin A, Demange L, Egecioglu E, Fehrentz JA, Martinez J, Dickson SL.
    Eur J Pharmacol; 2009 Jun 10; 612(1-3):167-73. PubMed ID: 19356720
    [Abstract] [Full Text] [Related]

  • 15. Evidence that central pathways that mediate defecation utilize ghrelin receptors but do not require endogenous ghrelin.
    Pustovit RV, Callaghan B, Ringuet MT, Kerr NF, Hunne B, Smyth IM, Pietra C, Furness JB.
    Physiol Rep; 2017 Aug 10; 5(15):. PubMed ID: 28801520
    [Abstract] [Full Text] [Related]

  • 16. Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor.
    Witherington J, Abberley L, Bellenie BR, Boatman R, Collis K, Dean DK, Gaiba A, King NP, Shuker N, Steadman JG, Takle AK, Sanger G, Butler S, McKay F, Muir A, Winborn K, Ward RW, Heightman TD.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):684-7. PubMed ID: 19128969
    [Abstract] [Full Text] [Related]

  • 17. On the central mechanism underlying ghrelin's chronic pro-obesity effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist.
    Salomé N, Hansson C, Taube M, Gustafsson-Ericson L, Egecioglu E, Karlsson-Lindahl L, Fehrentz JA, Martinez J, Perrissoud D, Dickson SL.
    J Neuroendocrinol; 2009 Sep 01; 21(9):777-85. PubMed ID: 19703102
    [Abstract] [Full Text] [Related]

  • 18. Glucagon receptor expression and glucagon stimulation of ghrelin secretion in rat stomach.
    Katayama T, Shimamoto S, Oda H, Nakahara K, Kangawa K, Murakami N.
    Biochem Biophys Res Commun; 2007 Jun 15; 357(4):865-70. PubMed ID: 17462598
    [Abstract] [Full Text] [Related]

  • 19. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs.
    Ozaki K, Sudo H, Muramatsu H, Yogo K, Kamei K, Koga H, Itoh Z, Omura S, Takanashi H.
    Inflammopharmacology; 2007 Feb 15; 15(1):36-42. PubMed ID: 17323194
    [Abstract] [Full Text] [Related]

  • 20. Motilin and ghrelin as prokinetic drug targets.
    De Smet B, Mitselos A, Depoortere I.
    Pharmacol Ther; 2009 Aug 15; 123(2):207-23. PubMed ID: 19427331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.